{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:10:47Z","timestamp":1784113847263,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20765"],"award-info":[{"award-number":["U24A20765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2321005"],"award-info":[{"award-number":["T2321005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpba.2026.117610","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:26:39Z","timestamp":1781205999000},"page":"117610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantification of isavuconazole in dried blood spots by LC\u2013MS\/MS and clinical application for therapeutic drug monitoring"],"prefix":"10.1016","volume":"280","author":[{"given":"Xiaoxue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117610_bib1","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.21037\/jtd-24-13","article-title":"Consensus for antifungal stewardship in China (2024 edition)","volume":"16","author":"Ye","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jpba.2026.117610_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmi.2024.08.006","article-title":"Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges","volume":"31","author":"Giannella","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jpba.2026.117610_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/tid.12751","article-title":"Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4","volume":"19","author":"Groll","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117610_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000952","article-title":"Antifungal Drugs TDM: Trends and Update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2026.117610_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/aac.00177-22","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117610_bib6","first-page":"295","article-title":"Chinese Society of Hematology, Chinese Medical Association, Consensus recommendations for the clinical application of isavuconazole (2023)","volume":"36","author":"Anti Infection Group","year":"2023","journal-title":"J. Clin. Hematol. (China)"},{"key":"10.1016\/j.jpba.2026.117610_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17512433.2023.2224562","article-title":"Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities","volume":"16","author":"M\u00fcller","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117610_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40572-020-00289-y","article-title":"Little to Give, Much to Gain-What Can You Do With a Dried Blood Spot?","volume":"7","author":"McClendon-Weary","year":"2020","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.jpba.2026.117610_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115438","article-title":"Quantification of nine psychotropic drugs in postmortem dried blood spot samples by liquid chromatography-tandem mass spectrometry for simple toxicological analysis","volume":"233","author":"Nishio","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117610_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/FTD.0000000000000994","article-title":"Best practices to implement dried blood spot sampling for therapeutic drug monitoring in clinical practice","volume":"44","author":"Francke","year":"2022","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2026.117610_bib11","unstructured":"Ministry of Health of the People\u2018s Republic of China, Measures for the clinical application management of antimicrobial drugs (Order No. 84 of the Ministry of Health), Beijing, 2012."},{"key":"10.1016\/j.jpba.2026.117610_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40261-025-01432-z","article-title":"An overview of isavuconazole clinical use: a multicentre analysis of indications, exposure and hepatic safety","volume":"45","author":"Bienvenu","year":"2025","journal-title":"Clin. Drug. Investig."},{"key":"10.1016\/j.jpba.2026.117610_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpba.2018.10.010","article-title":"Is the hematocrit still an issue in quantitative dried blood spot analysis?","volume":"163","author":"Velghe","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117610_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461731","article-title":"A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring","volume":"1635","author":"Tey","year":"2021","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2026.117610_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial: Volumetric absorptive microsampling (VAMS)","volume":"1046","author":"Protti","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2026.117610_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340797","article-title":"Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer\u00ae qDBS device","volume":"1242","author":"Deprez","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2026.117610_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4155\/bio-2022-0192","article-title":"Evaluation of hemaPEN\u00ae sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS\/MS","volume":"20","author":"Smidt","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2026.117610_bib18","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ac503931g","article-title":"New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis","volume":"4","author":"Leuthold","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117610_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115688","article-title":"Utilization of volumetric absorptive microsampling and dried plasma spot for quantification of anti-fungal triazole agents in pediatric patients by using liquid chromatography-tandem mass spectrometry","volume":"236","author":"Simeoli","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117610_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124590","article-title":"Quantification of isavuconazole from dried blood spots: Applicability in therapeutic drug monitoring","volume":"1258","author":"Martens-Lobenhoffer","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2026.117610_bib21","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/FTD.0000000000001352","article-title":"Simultaneous quantification of azole antimycotics in quantitative dried blood spots: a step toward home sampling for therapeutic drug monitoring","volume":"47","author":"Li","year":"2025","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2026.117610_bib22","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH harmonised tripartite guideline: Bioanalytical method validation (M10). \u3008https:\/\/www.ich.org\/page\/multidisciplinary-guidelines\u3009, 2022 (accessed 16 Jan 2026)."},{"key":"10.1016\/j.jpba.2026.117610_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring","volume":"4","author":"Capiau","year":"2019","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2026.117610_bib24","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/rcm.5182","article-title":"Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact","volume":"19","author":"Youhnovski","year":"2011","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"10.1016\/j.jpba.2026.117610_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462430","article-title":"Fully automated dried blood spot extraction coupled to liquid chromatography-tandem mass spectrometry for therapeutic drug Monitoring of immunosuppressants","volume":"1653","author":"Deprez","year":"2021","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2026.117610_bib26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4155\/bio.10.103","article-title":"The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs","volume":"8","author":"Denniff","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2026.117610_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10408363.2017.1343796","article-title":"Capillary blood for point-of-care testing","volume":"54","author":"Tang","year":"2017","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jpba.2026.117610_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/AJCP1L7DKMPCHPEH","article-title":"Drop-to-drop variation in the cellular components of fingerprick blood: implications for point-of-care diagnostic development","volume":"144","author":"Bond","year":"2015","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:57:45Z","timestamp":1784113065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526002785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0731708526002785"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117610","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of isavuconazole in dried blood spots by LC\u2013MS\/MS and clinical application for therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117610"}}